KLOW is a multi‑peptide research blend combining four well‑characterized peptides in a single lyophilized powder, designed for laboratory and in vitro research. The formulation brings together complementary peptides that are commonly investigated in scientific studies of tissue repair, inflammation, cellular signaling, and regenerative biology.
Key Components (per 80 mg blend):
-
GHK‑Cu (Copper Tripeptide‑1) – Copper‑bound tripeptide studied for collagen synthesis, tissue remodeling, and extracellular matrix modulation.
-
BPC‑157 (Body Protection Compound‑157) – Pentadecapeptide researched for healing pathways, vascular stability, and cytoprotective effects.
-
TB‑500 (Thymosin Beta‑4 fragment) – Peptide fragment explored for cell migration, angiogenesis, and actin cytoskeleton dynamics.
-
KPV (Lys‑Pro‑Val) – Tripeptide investigated for immune modulation and anti‑inflammatory responses.
Each of these peptides has been examined individually in a range of preclinical and in vitro models, and the KLOW blend allows researchers to study multi‑pathway interactions in complex biological systems.
Form & Appearance: Supplied as an 80 mg lyophilized (freeze‑dried) powder in sterile vials, often with a slight natural color due to copper complexes.
Intended Use:
Prepared strictly for research purposes only — KLOW is not FDA‑approved and not intended for human, veterinary, or clinical use. It’s intended for in vitro studies or controlled laboratory experiments conducted by qualified personnel.
Typical Research Applications:
• Tissue regeneration and repair models
• Studies on inflammatory modulation and immune responses
• Angiogenesis and extracellular matrix research
• Cellular signaling and peptide synergy investigations
